INTRODUCTION
Sedation procedures during magnetic resonance imaging (MRI) are raising new challenges for anesthesiologists 1 . Oral, rectal or intramuscular narcotics and barbiturates are occasionally inadequate to ensure a proper sedation without movement for children especially with mental retardation [1] [2] [3] [4] . In addition, MRI is a noninvasive but a noisy study, and patient must be completely immobile to obtain a good image [1] [2] [3] [4] . Because of these reasons, sedation or general anesthesia is needed [1] [2] [3] [4] . At this stage, the selected anest- hetic agent must be a fast-acting sedative and recovery must be in a short time 3, 5, 6 . Besides, the selected drug must have no adverse effects like vertigo, nausea and vomiting that may cause prolonged hospitalization. Seizure threshold must not be altered during the usage of this drug.
ABSTRACT

Implementation of sedatives during magnetic resonance imaging (MRI) in pediatric patients is often preferred. Propofol and midazolam are mostly chosen drugs, and it is suggested that
There are different reports about various sedative agents used in MRI studies 7 . Mostly preferred agents are pentobarbital, dexmedetomidine, propofol and midazolam 7 . Propofol has rapid induction, better recovery and quick catabolism without redistribution. It is usually the first-line drug for outpatient anesthesia procedures which does not cause nausea and vomiting 3 . However, the disadvantages are respiratory and hemodynamic depression, shorter duration of effect, dose-dependent effect, and absence of any antagonist drug 8 . Midazolam is used especially for its amnesic, anxiolytic and short acting effects. It was reported that propofol and midazolam had synergetic effects 6, 8 . It was suggested that synergetic effect was originated from interactive relationship among gamma-aminobutyric acid receptors 6 . This synergism causes alteration in propofol treatment and also adverse effects are decreased by this mechanism 4 .
There are reports about combination of propofol and midazolam at the pediatric age group in the literature. However, number of patients were not sufficient to make a decision, and meanwhile other drugs added in this combination hindered obtaining a clear result concerning the risks and effectiveness of propofolmidazolam treatment 3, 9 . As a result, debates are going on. Our study yielded similar outcomes with the studies of Machata et al. 3 , and Malviya et al. 10 . Although, adequately higher number of patients were enrolled in their study, data about the characteristic features of propofol-midazolam were not clearly demonstrated in this study 10 .
To the best of our knowledge, this serial has the largest population with 865 patients aiming to investigate the effectiveness and complications of propofolmidazolam combination in a standard and uniform protocol.
MATERIAL and METHOD
After the approval of local ethics committee (protocol #:2015/013, dated May 27, 2015, anesthesia and clinic charts of 865 children (0-18 years) sedated during MRI performed between January 2010 and December 2015 were evaluated retrospectively. Demographic parameters, ASA risk classifications, primary diseases, MRI evaluations and durations of imaging, anesthesia complications and adverse effects were evaluated.
Patients were evaluated in anesthesia department one day before MRI, and written informed consents were obtained. Precautions were elaborated according to ASA risk classifications. In the MRI department intravenous fluid was administered. Electrocardiography, noninvasive arterial blood pressure and peripheral oxygen saturations were monitored in a standard protocol, and oxygen was delivered at a rate of 4 L/min with face masks. After patients' stabilizations and securities were ensured, midazolam (0.1 mg kg -1 IV; max. 2.5 mg) (Zolamid®, Defarma, Turkey) and propofol (2 mg kg -1 IV; Propofol %1 Fresenius® vial, Fresenius Kabi, Austria) were administered. When Ramsay sedation scores (RSS) were 5 or greater, MRI was performed. Respiratory functions were especially monitored for depression. Airway and shoulder scrolls were used for the patients with hypoventilation. Secretions were aspirated. If aspiration failed, atropine was used. Endotracheal tubes were prepared for a probable emergency intubation. If patients made movements during imaging, propofol (1 mg kg -1 IV) was given. If the duration of imaging was longer than 30 minutes, propofol infusion was planned at a dose of 2 mg kg -1 h -1
. After the examinations, patients were taken to the recovery room. Patients were sent home after RSS were 3 and lower. In addition, oral intakes and general conditions were observed to make decisions for discharges. Similar articles were found for discussion. Only in one article our evaluation criteria were used. Therefore, we paid maximum attention to find out similar data in some other articles, and we excluded suspicious data even if the data seemed to be useful for consideration in this article.
Statistical Evaluation
Definitions of variables were performed where available. Predictive factors for complications like age, gender, weight, ASA risk classes, diagnosis and duration of the imaging were evaluated with univariate and multivariate regression analysis. P<0.05 was accepted as statistically significant. SPSS 17 (Chigago, USA) program was used for statistical assessments.
RESULTS
A total of 865 children between 0-18 years of age were evaluated for sedation procedures from January 2010 to December 2015. Demographic parameters of patients and ASA risk classifications are given in Table 1 . The youngest patient was 10 days old, weighed 2300 g with ASA IV and cranial MRI was performed with the indication of intractable seizures. Majority (79.9%) of the patients had primary neurological diseases as shown in Table 2 .
Cranial MRI was the most frequently used imaging modality in 85.2% of the cases, and procedural times are shown in Tables 3 and 4 . Two MRI examinations were terminated prematurely because of bronchospasm and head tilting. Except for these two patients, MRI was successfully performed in 99.7% of the cases. There were major complications and whole complication rate was 1.9%. Desaturation was the most common complication and it was seen in 4 (0.56%) patients (Table 5) . Respiratory depression was seen in 1.0% of the patients. Flumazenil (Anexate®, Deva, Istanbul, Turkey) was used to handle respiratory complications. According to ASA risk classifications, complications were mostly seen in ASA IV patients (p<0.005) (Figure 1 ). Median recovery time was 22.7±4.1 minutes. None of the patients were intubated.
DISCUSSION
MRI is an important radiological method in the diagnosis, treatment and follow-up of the patients. In addition, the importance of MRI augments after adding anesthesia facilities to this method. New imaging protocols have been specifically developed with the assistance of anesthesiologists in order to make successful MRI scans for babies and children 3, 5 .
Fast-acting anesthetic agents are mostly chosen drugs for MRI 7 . Leading agents in this issue are dexmedetomidine, propofol, midazolam, pentobarbital and sevoflurane 7 . However, the fast-acting features of these agents are not enough. A suitable agent must achieve supreme sedation, anxiety control, strong amnesia, immobility, rapid recovery and least psychogenic trauma for successful MRI examination 3 . In a study, it was stated that anesthetic agents had no significant difference as for sedative potency among each other 7 .
Propofol is the mainly preferred agent for outpatient practice 4, 6, 11 . One of the reason to choose propofol is its negligible effects on cortical functions 7 . Therefore, propofol is the most commonly used intravenous anesthetic agent for the sedation of pediatric patients 12 . Anesthesia induction depends on continuity of the dose and respiratory and hemodynamic depression may be seen 4, 6, 8 . In addition, propofol does not have its antagonist 4, 6, 8 .
Midazolam has very similar anesthetic efficiency with propofol 13 . It is preferred especially for its amnesic and anxiolytic effects, and it has a short-acting effect 6, 11 . Midazolam decreases disadvantages of propofol and recovery time and discharge from hospital is shortened with midazolam-propofol combination 8 . In a study, it was proved that midazolam decreased total induction dose of propofol at a rate of 23% 4 . Basic mechanism of this association is not clear but gamma-aminobutyric acid receptors are supposed to be mediators for this mutual effect 6 . Sedation or anesthesia management in diagnostic studies of children causes emergence of undesirable effects in 20% of the patients, and most of them (5.5%) consist of respiratory problems 14, 15 . Machata et al. 3 reported that respiratory problems were seen in 1% of their patients in their trial. In another study, propofol was administered in 50 patients and did not result in cardiac and respiratory problems 1 . Also, Havel et al. 16 reported that hypotension was not seen in their study. Contrary to the information like these, Usher et al. 17 reported that at the time their report was written, patient population was not sufficient to put forward data especially about respiratory and cardiac problems. In this study, one of 93 patients was treated with a minor manipulation for respiratory problem (putting a padding on the back), and one patient was treated with placement of an oral airway 17 . In our study, the common problem was desaturation (n=4, 0.56%). Simple manipulations like aspiration and oral airway placement for these patients were sufficient for treatment. Desaturation was seen in all patients with primary neurologic disorders and they all had oral defects. Periods of bradycardia were detected in 2 patients (0.28%) which did not cause serious problems.
Our study is very similar with the study of Machata et al. 3 . Allergic reactions and hiccup were not found in that study 3 . In our study allergic reactions and hiccup were present. These two problems were rarely defined in other studies. The problems might be seen coincidentally. On the other hand, it might be related to the propofol and midazolam combination. According to us, allergic reactions and hiccup may be seen in the larger-scale studies.
Head movement is one of the restrictive aspects on the success of MRI examination 17 . Intravenous propofol and nasal oxygenation are usually effective in stopping head movements, thus successful MRI examination can be achieved 17 . In our study, there was only one patient who repeatedly moved his head during MRI examination.
ASA III-IV patients were evaluated in a special group especially for outpatient procedures like MRI examinations. In the literature, ASA I-II patients are found eligible for MRI in general 4 . We did not compare some of the studies performed on ASA III-IV patients sedated during MRI examinations because sedation protocols of these patients were not clear for us 10 . ASA guidelines and related local guidelines are sufficient to provide optimum monitoring and equipment according to patients' circumstances 18, 19 . Machata et al. 3 evaluated 500 ASA I-II patients sedated with propofol. In this study propofol was used for sedation of the highest number of pediatric patients studied so far.In some articles like that of Machata et al. 3 patients with ASA III-IV risk classification were excluded from the study 5 . To our knowledge, ASA IV patients were sedated for MRI examination only in our study. A total of 267 ASA III-IV patients were sedated in our study. Not surprisingly, most of the complications were seen in ASA IV patients.
In conclusion, propofol-midazolam combination is a suitable selection to be used during MRI scans 1 . Our study revealed as in some other studies that propofol-midazolam combination can provide protection of respiration with lower incidence of adverse effects and complications in newborns, infants and older ages. In addition, ASA III-IV risk classifications do not provide definitive criteria for the indication of MRI scan. In our study, a significant increase in the number of complications related to ASA classification was present but all of them were slight complications which resolved with minor manipulations. Finally, this is the largest study focused on the use of only propofol-midazolam combination in the pediatric age group. Therefore, we can state that ours is an exceptional study so far.
